Aims: The aim was to measure the prefrontal cortical activity involved in shifting spatial attention to visual stimuli in the left or right visual field using near-infrared spectroscopy. Methods: Eleven participants performed a simple vigilance task, an endogenous attention task and an exogenous attention task. In the endogenous task, the left or the right side of the center diamond brightened, indicating the side for subsequent target appearance (controlled shift of attention). In the exogenous task, the peripheral squares brightened, indicating the appearance of target in those squares (reflexive shift of attention). Results: Stimuli at validly cued locations were responded to faster than stimuli at invalidly cued locations. Increases in oxyhemoglobin (oxy-Hb) were observed in the right prefrontal cortex throughout the 3 tasks, and in the left prefrontal cortex during the vigilance and the exogenous tasks. In the exogenous task, marked decreases in oxy-Hb were observed in the bilateral ventrolateral prefrontal cortex. Conclusions: These results suggest that the left and the right prefrontal cortices mediate distinct cognitive processes during the performance of visuospatial attentional tasks.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.